Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glioblastoma multiforme (GBM) is the most common and most malignant type of primary adult brain cancer. The most common phenotype associated with GBM is cellular invasion; however, the molecular mechanisms governing this process are poorly understood. Targeting protein for Xenopus
kinesin-like protein 2
(TPX2) is a nuclear protein with roles in cellular proliferation and mitotic spindle assembly. TPX2 is overexpressed in various malignancies, including human malignant astrocytoma. Despite this finding, the exact role of TPX2 in human
glioma
is not well defined. The present study reports the elevated expression of TPX2 in a number of
glioma
cell lines. TPX2 overexpression promoted cellular proliferation, decreased the percentage of cells in G0/G1 phase, and increased invasion of both U251 and U87 cells. Overexpression of TPX2 also significantly enhanced the phosphorylation of AKT, decreased the expression of p21, and increased the expression of cyclin D1 and matrix metallopeptidase (MMP)-9. In both U251 and U87 cells, knockdown of TPX2 resulted in phenotypes that are in direct contrast to those observed following TPX2 overexpression. Specifically, TPX2 knockdown inhibited cell proliferation, increased the percentage of cells in G0/G1 phase, inhibited invasion, decreased AKT phosphorylation, decreased the expression of MMP-9 and cyclin D1, and increased p21 expression. The AKT inhibitor IV in large part phenocopied the effect of TPX2 knockdown. The present data suggest that TPX2 promotes
glioma
cell proliferation and invasion via AKT signaling.
...
PMID:TPX2 promotes glioma cell proliferation and invasion via activation of the AKT signaling pathway. 2810 8
MicroRNA-1294 (miR-1294) has been reported to be involved in the progression of esophageal squamous cell carcinoma. However, the function and the mechanisms of miR-1294 in
glioma
remain unclear. In this study, we explore the potential biological roles of miR-1294 in
glioma
cell lines. First, we detected the aberrant down-regulation of miR-1294 in
glioma
tissues and cell lines. Second, we determined that miR-1294 suppresses the proliferation, migration and invasiveness and enhances the chemosensitivity of
glioma
cells lines to temozolomide. Third, we found that the targeting protein for Xenopus
kinesin-like protein 2
(TPX2) is the functional target of miR-1294; miR-1294 acts through TPX2 to exert an important biological effect in
glioma
. Importantly, TPX2 knockdown had the same effect on
glioma
cell lines as miR-1294 overexpression. In addition, when TPX2 was up-regulated in these cells, the effects of miR-1294 on
glioma
cell lines were suppressed. Moreover, the effect of miR-1294 on
glioma
was verified using a xenograft model. These findings demonstrated that miR-1294 inhibits the development of
glioma
by targeting TPX2. These findings provide a new potential therapeutic target for
glioma
treatment.
...
PMID:MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2. 2951 99